IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Cardiovascular Risk Evaluation and Antiretrovirals in HIV (CREATE1)
This study has been completed.
Sponsor:
King's College London
Collaborator:
Guy's and St Thomas' NHS Foundation Trust
Information provided by:
King's College London
ClinicalTrials.gov Identifier:
NCT01015092
First received: November 16, 2009
Last updated: NA
Last verified: November 2009
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk
| Condition |
|---|
| Cardiovascular Risk HIV Infections |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Predicted 10-year Coronary Heart Disease Risk in HIV and Implications for Clinical Management: the CREATE Study |
Resource links provided by NLM:
Further study details as provided by King's College London:
Primary Outcome Measures:
- 10 year predicted cardiovascular risk [ Time Frame: AT time of clinic attendence ]
Secondary Outcome Measures:
- coronary heart disease risk [ Time Frame: at time of clinic attendence ]
| Enrollment: | 1024 |
| Study Start Date: | June 2005 |
| Study Completion Date: | November 2006 |
| Primary Completion Date: | September 2006 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
unselected HIV outpatient attendees
All HIV patients attending for general HIV care at 2 London Hospitals
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Probability Sample |
Study Population
All HIV outpatients patients attending two London Hospitals
Criteria
Inclusion Criteria:
- Serologically proven HIV infection
- Attending general HIV outpatient clinic
Exclusion Criteria:
- Attending a specialist outpatient clinic which might lead to recruitment bias
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01015092
Please refer to this study by its ClinicalTrials.gov identifier: NCT01015092
Locations
| United Kingdom | |
| Guys & ST Thomas' Foundation Hospitals | |
| London, United Kingdom, SE30AA | |
Sponsors and Collaborators
King's College London
Guy's and St Thomas' NHS Foundation Trust
Investigators
| Principal Investigator: | Barry S Peters, MB BS. MD | King's College London |
More Information
| Responsible Party: | Dr Barry Stephen Peters, Kings College London |
| ClinicalTrials.gov Identifier: | NCT01015092 History of Changes |
| Other Study ID Numbers: |
05/Q0702/156 |
| Study First Received: | November 16, 2009 |
| Last Updated: | November 16, 2009 |
Keywords provided by King's College London:
|
HIV Cardiovascular Coronary hear disease HAART antiretroviral |
Additional relevant MeSH terms:
|
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
ClinicalTrials.gov processed this record on June 28, 2017